Methods of donor specific crossmatching

Details Methods of donor specific crossmatching Methods of donor specific crossmatching

2008-12-02

2011-10-11

Cheu, Jacob (Department: 1641)

Chemistry: analytical and immunological testing

Involving an insoluble carrier for immobilizing immunochemicals

Carrier is inorganic

C436S518000

Reexamination Certificate

active

08034635

ABSTRACT:
The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies and methods for donor-specific crossmatching.

REFERENCES:
patent: 4352883 (1982-10-01), Lim
patent: 4353888 (1982-10-01), Sefton
patent: 4654267 (1987-03-01), Ugelstad et al.
patent: 4714680 (1987-12-01), Civin
patent: 4965204 (1990-10-01), Civin
patent: 4968733 (1990-11-01), Muller et al.
patent: 4976859 (1990-12-01), Wechs
patent: 5026365 (1991-06-01), Rossini et al.
patent: 5035994 (1991-07-01), Civin
patent: 5071741 (1991-12-01), Brockbank
patent: 5084350 (1992-01-01), Chang et al.
patent: 5130144 (1992-07-01), Civin
patent: 5137809 (1992-08-01), Loken et al.
patent: 5158881 (1992-10-01), Aebischer et al.
patent: 5257984 (1993-11-01), Kelley
patent: 5284761 (1994-02-01), Aebischer et al.
patent: 5482841 (1996-01-01), Buelow
patent: 5518890 (1996-05-01), Starkweather et al.
patent: 5750397 (1998-05-01), Tsukamoto et al.
patent: 5800828 (1998-09-01), Dionne et al.
patent: 5840502 (1998-11-01), Van Vlasselaer
patent: 5843633 (1998-12-01), Yin et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5955291 (1999-09-01), Alitalo et al.
patent: 6017719 (2000-01-01), Tseng-Law et al.
patent: 6287875 (2001-09-01), Geisberg
patent: 6309643 (2001-10-01), Braun et al.
patent: 6376653 (2002-04-01), Holmes et al.
patent: 2002/0098166 (2002-07-01), Havemann et al.
patent: 2003/0100107 (2003-05-01), Peschle
patent: 2003/0148952 (2003-08-01), Crombleholme
patent: 2005/0244404 (2005-11-01), Sumitran-Holgersson et al.
patent: 2006/0035290 (2006-02-01), Popa et al.
patent: WO-92/04033 (1992-03-01), None
patent: WO-9219195 (1992-11-01), None
patent: WO-93/14191 (1993-07-01), None
patent: WO-9505452 (1995-02-01), None
patent: WO-95/07611 (1995-03-01), None
patent: WO-96/27287 (1996-09-01), None
patent: WO-96/29862 (1996-10-01), None
patent: WO-98/14058 (1998-04-01), None
patent: WO-00/24897 (2000-05-01), None
patent: WO-03/014326 (2003-02-01), None
Cerilli et al. “Endothelial Cell Alloantigen” Transplantation Proceedings, vol. XII, No. 3, Suppl 1 Sep. 1980, pp. 37-42.
Asahara et al., “Isolation of Putative Progenitor Cells for Angiogenesis”,Science, 275:964-967 (1997).
Bhatia et al., “A newly discovered class for human hematopoietic cells with SCID-repopulating activity”,Nat. Med.,49)1038-10454 (1998).
Borg A.A., “Antibodies to cytokeratins in inflammatory arthropathies”,Seminars in Arthritis and Rheumatism, 27(3):186-195 (1997).
Brasile et al., “Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis”,Am. J. Med., 87:74-80 (1989).
Brasile et al., “The association of antivascular endothelial cell antibody with hyperacute rejection: A case report”,Surgery, 99(5):637-640 (1986).
Cerilli et al., “The role of autoantibody to vascular endothelial cell antigens in atherosclerosis and vascular disease”,Transplantation Proceedings, 4(Suppl. 5):47-49 (1987).
Cerilli et al., “The Significance of the Monocyte Crossmatch in Recipients of Living-related HLA Identical Kidney Grafts”,Human Immunol., 7:45-50 (1983).
Chapman et al., “Immunoglobulin Class and Specificity of Antibodies Causing Postivie T Cell Crossmatches. Relationship to Renal Transplant Outcome”,Transplant., 42(6):608-613 (1986).
Civin et al., “Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells”,J. Immunol., 133:157-165 (1984).
Dimitriu-Bona et al., “Cytotoxicity to endothelial cells by sera from aged MRL/lpr/lpr mice is associated with autoimmunity to cell surface heparan sulfate”,Clin. Immunol. Immunopathol., 76(3)234-240 (1995).
Drake et al., “Isolation of endothelial cells from human first trimester decidua using immunomagnetic beads”,Human Reproduction, 6(8):1156-1159 (1991).
Elsheikh et al. Only a specific subset of human peripheral-blood Monocytes has endothelial-like functional capacity,Blood, 106(7):2347-2355(2005).
Gehling et al., “In vitro differentiation of endothelial cells from AC133-positive progenitor cells”,Blood, 95:3106-3112 (2000).
George et al., “Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty”,Thrombosis and Haemostasis, 67(1):147-153 (1992).
Gruber, S.A., “The Case for Local Immunosuppression”,Transplant., 54(1): 1-11 (1992).
Holyoake, T.L., “The CD34 antigen: Potential clinical advantages of CD34 selection”,Clin. Oncol., 8:214-221 (1996).
Hosenpud et al., “Cardiac Allograft Vasculopathy. Association with Cell-Mediated but Not Humoral Alloimmunity to Donor-Specific Vascular Endothelium”,Circulation, 92(2):205-211 (1995).
Ianhez et al., “Humoral Rejection with Negative Crossmatches”,Transplant. Proceedings, 21(1):720-721 (1989).
Jackson et al., “Binding of human endothelium to Ulex europaeus I-coated Dynabeads: application to the isolation of microvascular endothelium”,J. Cell Sci., 96:257-262 (1990).
Jones et al., “Isolation and characterization of rat gastric microvascular endothelial cells as a model for studying gastric angiogenesis in vitro”,J. Physiol. Pharmacol., 51(4):813-820 (2000).
Joplin et al., “Immuno-isolation and culture of biliary epithelial cells from normal human liver”, In VitroCell. Dev. Biol., 25:1189-1192 (1989).
Kalil et al., “Humoral Rejection in Two HLA Identical Living Related Donor Kidney Transplants”,Transplant. Proceedings, 21(1):711-713 (1989).
Karlsson et al., “Nucleation and Growth of Ice Crystals Inside Cultured Hepatocytes During Freezing in the Presence of Dimethyl Sulfoxide”,Biophys. J., 65:2524-2536 (1993).
Kissmeyer-Nielsen et al., “Hyperacute Rejection of Kidney Allografts, Associated with Pre-Existing Humoral Antibodies Against Donor Cells”,Lancet, 2(7465):662-665 (1966).
Matsubara et al., “Isolation and culture of rat retinal microvessel endothelial cells using magnetic beads coated with antibodies to PECAM-1”,Current Eye Res., 20(1):1-7 (2000).
Mohanakumar et al., “Serological Characterization of Antibodies Eluted From Chronically Rejected Human Renal Allografts”,Transplant., 32(1):61-66 (1981).
Moraes et al., “Alloantibodies Against Donor Epidermis and Early Kidney Transplant Rejection”,Transplant., 51(2):370-373 (1991).
Murohara et al., “Transplanted cord blood-derived endothelial precursor cell augment postnatal neovascularization”,J. Clin. Invest., 105(11):1527-1536 (2000).
Nowak et al., “Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization”,Circulation, 110(24):3699-3707 (2004).
Osawa et al., “Long-term lymphohematopoietic reconstitution by a single CD34-low
egative hematopoietic stem cell”,Science, 273:242-245 (1996).
Paul et al., “Antibodies Against Renal Endothelial Alloantigens”,Transplant. Proc., 12(3, Suppl. 1):43-48 (1980).
Peichev et al., “Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursorsExpression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors”,Blood, 95(3):952-958 (2000).
Perrey et al., “An association between antibodies specific for endothelial cells and renal transplant failure”,Transplant Immunol., 6:101-106 (1998).
Pierce et al., “A Mixed Antiglobulin Test With Kidney Cells in Suspension for IgG Antibody in Human Allograft Recipients”,Transplant., 19(4):343-348 (19

Affiliated with

Also associated with

Rating

Methods of donor specific crossmatching does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of donor specific crossmatching, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of donor specific crossmatching will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4278655